Researchers compared rates of symptoms prior to infection and rate of long-term symptoms post-infection in three groups. The study population included: COVID-19 patients between Jan. 1, 2020, and July 1, 2021; non-COVID, non-influenza viral pneumonia patients between Jan. 1, 2018, and July 1, 2019; and influenza patients between Jan. 1, 2018, and July 1, 2019.
Three key findings:
- An additional 3.7 percent of patients reported new long-term symptoms after COVID-19 and pneumonia infections.
- An additional 1.5 percent of influenza patients reported new long-term symptoms.
- Among hospitalized patients, an additional 5.4 percent of COVID-19 patients, 6.4 percent of influenza patients and 5.2 percent of viral pneumonia patients sought treatment for long-term symptoms following infection.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
